Healthy high growth potential

Results

1515

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1515 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
ADMR
Rp1,660.0014.5%62.7%Rp67.9tRp2,418.2813.126.8%2.8%Materials
COXG
€12.20-8.6%30.6%€1.0b€15.3515.124.7%n/aUtilities
FWRY
ج.م18.741.8%71.9%ج.م62.7bج.م20.3325.427.2%n/aDiversified Financials
AGP
€7.032.0%-13.5%€128.2m€8.5725.837.8%n/aCapital Goods
KEBNI B
SEK 1.266.1%-31.9%SEK 343.9mSEK 1.603.082.7%n/aTech
AXSM
US$253.407.8%149.2%US$13.1bUS$275.2818.457.3%n/aPharmaceuticals & Biotech
RHM
€1,150.20-4.1%-34.6%€53.5b€1,889.3851.030.8%1.0%Capital Goods
LITE
US$957.2416.5%1,008.6%US$71.7bUS$1,111.29169.679.1%n/aTech
CRDO
US$259.4116.7%227.7%US$46.3bUS$256.30101.327.5%n/aSemiconductors
NVDA
US$212.452.0%47.4%US$5.0tUS$298.9332.221.8%0.5%Semiconductors
CDR
zł222.50-2.0%-16.0%zł22.2bzł234.5643.126.9%0.4%Media
SVM
CA$17.0714.8%186.4%CA$3.5bCA$22.056.286.1%0.2%Materials
MOD
US$285.723.8%198.1%US$14.5bUS$340.86124.249.2%n/aCapital Goods
CORT
US$83.1213.4%17.2%US$8.9bUS$88.00191.148.9%n/aPharmaceuticals & Biotech
MDGL
US$499.767.0%75.3%US$11.1bUS$678.7110.259.2%n/aPharmaceuticals & Biotech
2368
NT$1,340.00-10.4%398.1%NT$667.1bNT$1,485.0059.738.2%0.7%Tech
6787
JP¥34,850.001.6%434.5%JP¥780.3bJP¥22,733.3345.927.9%0.5%Tech
456A
JP¥1,657.001.8%n/aJP¥163.2bn/a51.622.6%n/aRetail
5038
JP¥1,739.00-1.6%-31.2%JP¥26.1bJP¥3,140.0023.420.1%1.2%Healthcare
9218
JP¥693.002.7%3.4%JP¥7.3bn/a30.642.1%1.4%Healthcare
002970
CN¥67.491.0%43.6%CN¥12.1bn/a37.736.5%1.5%Automobiles
688072
CN¥655.809.8%367.0%CN¥188.5bCN¥511.08112.234.1%0.05%Semiconductors
PNI
AU$17.1412.2%-13.8%AU$3.9bAU$22.3131.921.1%3.3%Diversified Financials
300432
CN¥23.564.6%93.9%CN¥39.3bCN¥34.4079.560.7%0.4%Automobiles
Page 1 of 43